A TORC1/2 inhibitor onatasertib combined with toripalimab in patients with advanced cervical cancers with prior anti-PD-(L)1 therapy.

Authors: Li Zheng, Guiling Li, Qin Yang, Keqiang Zhang, Lin Lai, Jinsheng Hong, Li Yuan, Chu-Ying Huang, Yongsheng Wang, Jun Zhao, Hui Xie, Qi Zhou

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.5540

Source: Full article

---

Abstract

5540